Exodus Point Capital Management, LP Genocea Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.33 $19,367 - $25,935	-11,131 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.06 - $2.82 $206 - $282	-100 Reduced 0.89%	11,131 $26,000
Q1 2021 May 17, 2021	BUY	$2.35 - $4.01 $26,392 - $45,036	11,231 New	11,231 $30,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.